Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer
ACS Applied Bio Materials · 18.06.2026
DOI: 10.1021/acsabm.6c00573 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 18.06.2026. Verfasst von Haoqi Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience an…. Hauptthemen laut MEDLINE: Cisplatin, Esophageal Neoplasms, S100 Calcium-Binding Protein A4, Drug Resistance, Neoplasm. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
- University of Chinese Academy of Sciences, Beijing 101408, China.
- Department of Thoracic Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
- School of Medicine, Nankai University, Tianjin 300071, China.
ORCID-Profile: Lei Miao, Wenfu Zheng, Tianjiao Ji
Förderung
- Beijing Municipal Science and Technology Commission
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Yu, H., Ma, X., Chen, R., Miao, L., Lu, Z., Lin, Y., Liu, Y., Zheng, W., Ji, T., & Yang, B. (2026). Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00573
Vancouver
Yu H, Ma X, Chen R, Miao L, Lu Z, Lin Y, et al. Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00573
BibTeX
@article{Yu2026,
author = {Yu, Haoqi and Ma, Xu and Chen, Ruiji and Miao, Lei and Lu, Zhihao and Lin, Yingxue and Liu, Yang and Zheng, Wenfu and Ji, Tianjiao and Yang, Bo},
title = {Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00573}
}
EUVIMED